EyePoint

IPO

EyePoint is committed to developing therapeutics to improve the lives of patients with serious retinal disease.

Public · Watertown, United States · Founded 1987 · $60.5M raised

Employees
51–200
Founded
1987
Business Model
B2B
Total Funding
$60.5M
Last Round
$60.5M Corporate RoundMar 2018
Rounds
1
Type
Public

About

Clinical-stage biotech developing innovative sustained-release therapeutics for serious retinal diseases.

Summary

EyePoint is a Biotechnology company based in Watertown, United States, founded in 1987. It has raised $60.5M in total across 1 round, most recently a $60.5M Corporate Round round in Mar 2018. Investors include Essex Woodlands Health Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Secondary MarketPost-IPO Equity RoundJan 2021
$15.7M

Sign up to see all 5 rounds

IPO through Secondary Market — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EyePoint on Indexed.vc
<a href="https://indexed.vc/companies/eyepoint"><img src="https://indexed.vc/api/badge/company/eyepoint" alt="EyePoint on Indexed.vc" width="260" height="76" /></a>